Black Diamond Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 10.73 M | $46.70 M | 0.70% | 19.00% |
| BELLEVUE GROUP AG | 11/14/2024 | 8.52 M | $37.05 M | 0.00% | 15.07% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 5.03 M | $21.87 M | 139.45% | 8.90% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 4.45 M | $19.35 M | 0.00% | 7.87% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.50 M | $15.22 M | 100.00% | 6.19% |
| VANGUARD GROUP INC | 11/13/2024 | 2.32 M | $10.08 M | 8.74% | 4.10% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.37 M | $5.96 M | -14.53% | 2.42% |
| SIREN, L.L.C. | 11/13/2024 | 1.05 M | $4.55 B | 100.00% | 1.85% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 950,000 | $4.13 M | 100.00% | 1.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 944,877 | $4.11 M | 12.16% | 1.67% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 872,680 | $3.80 M | 48.26% | 1.54% |
| STATE STREET CORP | 11/14/2024 | 809,196 | $3.52 M | 17.20% | 1.43% |
| CITADEL ADVISORS LLC | 11/14/2024 | 703,704 | $3.06 M | 15,437.73% | 1.25% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 700,000 | $3.05 M | 100.00% | 1.24% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 697,125 | $3.03 M | 100.00% | 1.23% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 657,036 | $2.86 M | -6.58% | 1.16% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 594,000 | $2.58 M | 100.00% | 1.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 555,111 | $2.41 M | -8.38% | 0.98% |
| BOXER CAPITAL, LLC | 11/14/2024 | 506,000 | $2.20 M | 0.00% | 0.90% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 379,944 | $1.65 M | -53.27% | 0.67% |
| UBS OCONNOR LLC | 11/14/2024 | 300,000 | $22,500 | 546.55% | 0.53% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 284,700 | $1.24 M | 100.00% | 0.50% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 284,153 | $1.24 M | -0.94% | 0.50% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 281,016 | $1.22 M | 345.21% | 0.50% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 255,857 | $1.11 M | 27.90% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 253,800 | $1.10 M | -3.83% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 226,745 | $986,341 | -77.44% | 0.40% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 219,678 | $929,238 | -17.51% | 0.39% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 211,600 | $920,460 | 100.00% | 0.37% |
| HAP TRADING, LLC | 11/12/2024 | 209,900 | $36,365 | 100.00% | 0.37% |
| LMR PARTNERS LLP | 11/07/2024 | 206,400 | $897,840 | 100.00% | 0.37% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 204,957 | $891,563 | 12.82% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 192,800 | $838,680 | 1,621.43% | 0.34% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 184,200 | $801,270 | 100.00% | 0.33% |
| FMR LLC | 11/13/2024 | 179,068 | $778,945 | 100.00% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 178,733 | $777,488 | 46.50% | 0.32% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 150,324 | $653,909 | 1.91% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 149,200 | $649,020 | -13.76% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 141,733 | $616,538 | 30.08% | 0.25% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 135,868 | $591,026 | 100.00% | 0.24% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 126,100 | $548,535 | 100.00% | 0.22% |
| MORGAN STANLEY | 11/14/2024 | 125,004 | $543,767 | -42.22% | 0.22% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 125,000 | $543,750 | 100.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 109,224 | $475,124 | 6.87% | 0.19% |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 10/21/2024 | 102,300 | $445,005 | -9.91% | 0.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 100,000 | $435,000 | 100.00% | 0.18% |
| MARSHALL WACE, LLP | 11/14/2024 | 97,166 | $422,672 | 2.78% | 0.17% |
| NEWTYN MANAGEMENT, LLC | 11/14/2024 | 95,000 | $413,250 | 0.00% | 0.17% |
| UBS OCONNOR LLC | 11/14/2024 | 90,706 | $394,571 | -70.13% | 0.16% |
| CITADEL ADVISORS LLC | 11/14/2024 | 88,400 | $384,540 | 1,145.07% | 0.16% |
Black Diamond Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of Black Diamond Therapeutics, Inc.. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 10.73 M
Bellevue Group AG: 8.52 M
Vestal Point Capital, LP: 5.03 M
NEA Management Company, LLC: 4.45 M
BlackRock Funding, Inc. /DE: 3.5 M
VANGUARD GROUP INC: 2.32 M
85.96% of Black Diamond Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 52.46 M shares in the last 24 months. This purchase volume represents approximately $116.45 M in transactions.